Novel Orexin Drug Improves Cognitive Symptoms of Narcolepsy Type 1

(MedPage Today) — The investigational orexin receptor 2 (OX2R) agonist oveporexton improved cognitive symptoms of narcolepsy type 1 (NT1) in secondary analysis of a phase II trial.
The oral agent improved attention, memory, and executive function…

Source link : https://www.medpagetoday.com/neurology/sleepdisorders/118910

Author :

Publish date : 2025-12-09 16:57:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Novel Orexin Drug Improves Cognitive Symptoms of Narcolepsy Type 1

Ianalumab’s Success in Phase III Trials Marks a Turning Point in Sjögren’s Disease

PA- and Physician-Led Heart Transplant Recovery Comparable

Related Posts

Psoriatic Disease: QOL Improved With GLP-1 RA Plus Biologic

Nearly Half of Americans Expected to Have Obesity in the Next 10 Years

A Call to Consider Patients’ Medication List When Prescribing Cancer Immunotherapy

How to Survive Night Shifts as a Resident

Next DSM Insights; FDA Reviewing Non-Stimulant ADHD Drug; 10M People Microdosing

Viral and Nonviral NICU Infection Rates Diverged During the COVID Pandemic

Psoriatic Disease: QOL Improved With GLP-1 RA Plus Biologic

Nearly Half of Americans Expected to Have Obesity in the Next 10 Years

A Call to Consider Patients’ Medication List When Prescribing Cancer Immunotherapy

How to Survive Night Shifts as a Resident

Next DSM Insights; FDA Reviewing Non-Stimulant ADHD Drug; 10M People Microdosing

Viral and Nonviral NICU Infection Rates Diverged During the COVID Pandemic

NIH Data Misused for ‘Race Science’; RFK Jr.’s Autism Committee; NIH Panels at Risk

Study Suggests Some Tap Water May Raise Blood Pressure

Categories

Archives